Urine drug screening: A valuable office procedure

American Family Physician

Volumn 81, Issue 5, 2010, Pages 635-640

  Standridge, John B ^a,b   Adams, Stephen M ^a   Zotos, Alexander P ^b  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b Council for Alcohol and Drug Abuse Services ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CANNABIS; CODEINE; DIAMORPHINE; FENTANYL; HYDROCODONE; METHADONE; MORPHINE; OPIATE; OXYCODONE; TRAMADOL;

ARTICLE; DIAGNOSTIC TEST; DRUG DETERMINATION; DRUG SCREENING; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MASS SPECTROMETRY; NONHUMAN; PATIENT ATTITUDE; PATIENT COMPLIANCE; RELIABILITY; URINALYSIS;

EID: 77949732943     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Katz NP, Sherburne S, Beach M, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97(4):1097-1102.
2. Manubay JM, Comer SD, Sullivan MA. Treatment selection in substance abusers with pain. Adv Pain Manage. 2008;2(2):59-67.
3. U.S. Department of Justice. Drug Enforcement Administration. Dispensing controlled substances for the treatment of pain. September 2006. http://www.deadiversion.usdoj.gov/fed-regs/notices/2006/fr09062.htm. Accessed January 16, 2010.
4. Turk DC, Swanson KS, Gatchel RJ. Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain. 2008;24(6):497-508.
5. Ives TJ, Chelminski PR, Hammett-Stabler CA, et al. Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res. 2006;6:46.
6. Schiller MJ, Shumway M, Batki SL. Utility of routine drug screening in a psychiatric emergency setting. Psychiatr Serv. 2000;51(4):474-478.
7. Crosby RD, Carlson GA, Specker SM. Simulation of drug use and urine screening patterns. J Addict Dis. 2003;22(3):89-98.
8. Michna E, Jamison RN, Pham LD, et al. Urine toxicology screening among chronic pain patients on opioid therapy: frequency and predictability of abnormal findings. Clin J Pain. 2007;23(2):173-179.
9. Levy S, Sherritt L, Vaughan BL, Germak M, Knight JR. Results of random drug testing in an adolescent substance abuse program. Pediatrics. 2007;119(4): e843-e848.
10. Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians [published correction appears in Mayo Clin Proc. 2008;83(7):851]. Mayo Clin Proc. 2008;83(1):66-76.
11. Luzzi VI, Saunders AN, Koenig JW, et al. Analytic performance of immunoassays for drugs of abuse below established cutoff values. Clin Chem. 2004;50(4):717-722.
12. Baden LR, Horowitz G, Jacoby H, Eliopoulos GM. Quinolones and false-positive urine screening for opiates by immunoassay technology. JAMA. 2001;286(24):3115-3119.
13. Matos ME, Burns MM, Shannon MW. False-positive tricyclic antidepressant drug screen results leading to the diagnosis of carbamazepine intoxication. Pediatrics. 2000;105(5):E66.
14. Manchikanti L, Atluri S, Trescot AM, Giordano J. Monitoring opioid adherence in chronic pain patients: tools, techniques, and utility. Pain Physician. 2008;11(2 suppl): S155-S180.
15. Jaffee WB, Trucco E, Levy S, Weiss RD. Is this urine really negative? A systematic review of tampering methods in urine drug screening and testing. J Subst Abuse Treat. 2007;33(1):33-42.
16. U.S. Department of Health and Human Services. Substance Abuse and Mental Health Services Administration Division of Workplace Programs. Urine specimen collection handbook for federal agency workplace drug testing programs. November 2004. http://workplace. samhsa.gov/DrugTesting/Level-1-Pages/ HHS%20Urine%20Specimen%20Collection%20Handbook%20(Effective%20November%201, %202004).aspx. Accessed January 7, 2009.
17. Specimen Validity Testing. Substance Abuse and Mental Health Services Administration Division of Workplace Programs. February 2005. http://workplace.samhsa.gov/DrugTesting/Files-Drug-Testing/Labs/ Specimen%20Validity%20Testing%20-%20February%202005.pdf. Accessed January 7, 2009.